Brind.

Analysis Contrasts CF Industries and Novozymes A/S Stock Profiles

1 report, 1 independent Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A comparison of CF Industries and Novozymes A/S found that CF Industries has higher revenue and earnings than Novozymes A/S. CF Industries is also trading at a lower price-to-earnings ratio, suggesting it is currently more affordable. CF Industries shares are held by 93.1% institutional investors, compared to 0.0% of Novozymes A/S shares.

From themarketsdaily.com

Why it matters

Some supportBrind's analysis of the reports

The comparison highlights differences in market perception and risk profiles between the two large-cap materials companies. CF Industries has a beta of 0.4, indicating its stock price is 60% less volatile than the S&P 500, while Novozymes A/S has a beta of 0.93.

From themarketsdaily.com

Who's involved

  • CF IndustriesNorth American manufacturer and distributor of agricultural fertilizers

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped